These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2370301)

  • 21. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
    Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
    Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.
    Hollenberg NK; Chenitz WR; Adams DF; Williams GH
    J Clin Invest; 1974 Jul; 54(1):34-42. PubMed ID: 4365595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition.
    Nicoletti I; Filipponi P; Fedeli L; Gregorini G; Ambrosi F; Sfrappini M; Santeusanio F; Brunetti P
    Horm Metab Res; 1984 Dec; 16(12):658-62. PubMed ID: 6441763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of vascular and adrenal responsiveness to angiotensin II following calcium channel blockade.
    Conlin PR; Seely EW; Hollenberg NK; Williams GH
    Endocr Res; 1998 May; 24(2):127-39. PubMed ID: 9738692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
    Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of angiotensin II, adrenocorticotropin, and potassium on aldosterone production in adrenal zona glomerulosa cells from streptozotocin-induced diabetic rats.
    Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Uchida K; Konishi F; Morimoto S
    Endocrinology; 1986 Jan; 118(1):183-8. PubMed ID: 3000733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
    Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
    J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic modulation of aldosterone secretion in the rat.
    Aguilera G; Catt KJ
    Endocrinology; 1984 Jan; 114(1):176-81. PubMed ID: 6317344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
    Williams GH; Hollenberg NK
    J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenocorticotropin.
    Carey RM
    J Clin Endocrinol Metab; 1982 Feb; 54(2):463-9. PubMed ID: 6274907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects.
    Melis GB; Paoletti AM; Mais V; Mastrapasqua NM; Strigini F; Fruzzetti F; Guarnieri G; Gambacciani M; Fioretti P
    J Clin Endocrinol Metab; 1982 Mar; 54(3):485-9. PubMed ID: 6799535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of sodium intake on angiotensin content of the rat adrenal gland.
    Kifor I; Moore TJ; Fallo F; Sperling E; Menachery A; Chiou CY; Williams GH
    Endocrinology; 1991 Mar; 128(3):1277-84. PubMed ID: 1999148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of low normal and high normal sodium intake on hormonal and metabolic responses to ACTH, angiotensin II and an acute salt load in normal subjects.
    Schiffrin EL; Gutkowska J; Julesz J; Thibault G; Genest J
    Clin Invest Med; 1984; 7(3):149-55. PubMed ID: 6097382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in adrenal responsiveness and potassium balance with shifts in sodium intake.
    Adler GK; Moore TJ; Hollenberg NK; Williams GH
    Endocr Res; 1987; 13(4):419-45. PubMed ID: 3329091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased water excretion in hyperprolactinemic rats.
    Adler RA; Herzberg VL; Brinck-Johnsen T; Sokol HW
    Endocrinology; 1986 Apr; 118(4):1519-24. PubMed ID: 3004920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of dopamine in nonmodulating hypertension.
    Gordon MS; Steunkel CA; Conlin PR; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1989 Aug; 69(2):426-32. PubMed ID: 2753983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.